Clinical and Translational Research
Copyright ©The Author(s) 2023.
World J Clin Cases. May 26, 2023; 11(15): 3444-3456
Published online May 26, 2023. doi: 10.12998/wjcc.v11.i15.3444
Figure 6
Figure 6 Differences in IC50 values of different drugs between high and low risk groups. A: IC50 values of cisplatin between high and low risk groups; B: IC50 values of Docetaxel between high and low risk groups; C: IC50 values of vinblastine between high and low risk groups; D: IC50 values of Doxorubicin between high and low risk groups; E: IC50 values of Mitormycin. C between high and low risk groups.